Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
28,529,838
-
Share change
-
+3,575,499
-
Total reported value
-
$5,239,051,095
-
Put/Call ratio
-
64%
-
Price per share
-
$183.64
-
Number of holders
-
245
-
Value change
-
+$658,436,118
-
Number of buys
-
149
-
Number of sells
-
109
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q2 2024
As of 30 Jun 2024 Krystal Biotech, Inc. - COMMON STOCK (KRYS) had 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,529,838 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Redmile Group, LLC, Frazier Life Sciences Management, L.P., Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, and DIMENSIONAL FUND ADVISORS LP.
This table shows 245 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.